Cleavage of transcriptional activator Oct-1 by poliovirus encoded protease 3Cpro

Virology
P YalamanchiliA Dasgupta

Abstract

In HeLa cells, RNA polymerase II mediated transcription is severely inhibited by poliovirus infection. Both basal and activated transcription are affected to bring about a complete shutoff of host cell transcription. We demonstrate here that the octamer binding transcription factor, Oct-1, is cleaved in HeLa cells infected with poliovirus. Incubation of Oct-1 with the purified, recombinant 3Cpro results in the generation of the cleaved Oct-1 product seen in virus infected cells. Poliovirus infection leads to the formation of altered Oct-1 DNA complexes that can also be generated by incubation of Oct-1 with purified 3Cpro. We also show that Oct-1 cleaved by 3Cpro loses its ability to inhibit transcriptional activation by the SV40 B enhancer. These results suggest that cleavage of Oct-1 in poliovirus infected cells leads to the loss of its activity.

References

Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·S T SmaleD Baltimore
Oct 1, 1990·Molecular and Cellular Biology·M E Clark, A Dasgupta
Jul 1, 1985·Molecular and Cellular Biology·M AresA M Weiner
Apr 7, 1989·Cell·S T Smale, D Baltimore
Dec 8, 1988·Nature·R A Sturm, W Herr
Dec 1, 1981·Cell·N CrawfordD Baltimore
Feb 1, 1993·Molecular and Cellular Biology·M E ClarkA Dasgupta

❮ Previous
Next ❯

Citations

Mar 1, 2012·Nucleic Acids Research·David PiñeiroEncarnación Martínez-Salas
Jun 22, 2007·Journal of Virology·Rushika PereraBert L Semler
Apr 15, 2003·Journal of Virology·Pranav DanthiMarie Chow
Feb 28, 2006·Journal of Virology·Peter V LidskyVadim I Agol
Nov 8, 2012·MBio·Janet M RozovicsBert L Semler
Dec 6, 2000·Microbiology and Molecular Biology Reviews : MMBR·D S Lyles
Nov 21, 2009·Journal of Biomedical Science·Jing-Yi LinShin-Ru Shih
Dec 31, 2011·The Journal of Infectious Diseases·Soo-Hyeon YunEun-Seok Jeon
Dec 30, 2006·Apoptosis : an International Journal on Programmed Cell Death·David H W ChauDecheng Yang
Jan 16, 2003·Virus Research·Peter W MasonBarry Baxt
Dec 3, 2014·International Journal of Cardiology·Chandirasegaran MassilamanyJay Reddy
Dec 13, 2005·Trends in Microbiology·Eric J Buenz, Charles L Howe
Nov 24, 2005·Virus Research·Richard E Lloyd
Nov 17, 2007·Cell Host & Microbe·James P WhiteRichard E Lloyd
Dec 25, 2012·Antiviral Research·Luqing ShangZheng Yin
Oct 21, 2000·Virology·V PietiäinenT Hyypiä
Sep 29, 2011·Biochemical and Biophysical Research Communications·Enrique ÁlvarezJosé M Izquierdo
May 5, 2016·Reviews in Medical Virology·Olli H LaitinenMalin Flodström-Tullberg
Mar 30, 2012·PLoS Genetics·Pamela A BarendtCasim A Sarkar
Nov 28, 2007·Annual Review of Pathology·Mitra Esfandiarei, Bruce M McManus

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.